EUVIMEDEUVIMED entdecken
CrossrefInfokarte

From Liver to Muscle: Crosstalk Mechanisms and Interventions in Sarcopenia

Qiquan Wang, Meng Yao, Xiang Wang, Xinqiang Lan, Gailing Fan, Yang Xiang

Health and Metabolism · 2025

DOI: 10.53941/hm.2025.100022 ↗
AbstractBibliografische Angaben

Abstract

Aging is a complex and multifactorial process, characterized by a gradual decline of multiple organ systems. Increasing evidence suggests that organ crosstalk plays a crucial role in aging. It is particularly important in the development of age-related diseases like sarcopenia. The liver significantly impacts skeletal muscle health by influencing metabolic health, inflammatory signals, and the secretion of hepatokines. Chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC), exacerbate sarcopenia by disruptiong the liver-muscle interactions. Recent studies have demonstrated that liver-derived metabolites, including ketone bodies, can modulate the skeletal muscle function. Notably, beta-hydroxybutyrate (BHB), a key liver-derived metabolite, has been shown to mediate post-translational modifications (PTMs) in muscle, reversing sarcopenia through beta-hydroxybutyrylation. This review explores the relationship between liver aging, chronic liver diseases, and sarcopenia. It focuses on mediators of liver-muscle crosstalk, including metabolic integration, hepatokines, and miRNAs in extracellular vesicles (EVs). We highlight the impact of liver-derived metabolites on skeletal muscle post-translational modifications, particularly the role of BHB in muscle rejuvenation and sarcopenia reversal. Understanding these mechanisms provides new insights into potential therapeutic strategies for mitigating sarcopenia via living aging intervention.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →